Karin Eklund Vanderpol
Profile
Karin Eklund Vanderpol formerly worked at Swedish Orphan Biovitrum AB, as Director-Global Regulatory Affairs, AstraZeneca AB, as Head-Regulatory Affairs, and Oncopeptides AB, as Head-Regulatory Affairs from 2020 to 2022.
Ms. Vanderpol received her graduate degree from the University of Uppsala.
Former positions of Karin Eklund Vanderpol
| Companies | Position | End |
|---|---|---|
| ONCOPEPTIDES AB | General Counsel | 2021-12-31 |
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 2019-11-30 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | General Counsel | - |
Training of Karin Eklund Vanderpol
| University of Uppsala | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Karin Eklund Vanderpol
